{"id":"W2805006390","doi":"10.1016/j.ejphar.2018.05.027","title":"Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT","year":2018,"lang":"en","type":"article","venue":"European Journal of Pharmacology","topic":"Silymarin and Mushroom Poisoning","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Project 211; Higher Education Discipline Innovation Project; National Natural Science Foundation of China; American Society of Preventive Oncology; Cancer Research Society; American Association for Cancer Research","keywords":"Silibinin; Sorafenib; Cancer research; Protein kinase B; STAT3; XIAP; MAPK/ERK pathway; Homeobox protein NANOG; Pharmacology; Medicine; Apoptosis; Chemistry; Signal transduction; Hepatocellular carcinoma; Programmed cell death; Caspase; Biochemistry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001141346,0.0004340566,0.000537209,0.000332262,0.0001789191,0.0002961352,0.0001769931,0.0002468508,0.002423846],"category_scores_gemma":[0.00008156217,0.0001445286,0.0004237819,0.0001984251,0.0001893527,0.0002663791,0.0002135523,0.0006398936,0.0003385008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002574727,"about_ca_system_score_gemma":0.0004461644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006126822,"about_ca_topic_score_gemma":0.002287445,"domain_scores_codex":[0.9998808,0.00001549832,0.00001090641,0.00001779749,0.00003209766,0.00004282041],"domain_scores_gemma":[0.9999689,0.000004712429,0.000006423264,0.00000294546,0.000004450041,0.00001261527],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002154759,0.0003919922,0.0008264766,0.0003011588,0.00008560823,0.0001324268,0.00004588295,0.0003858406,0.9770468,0.0002734402,0.0006555712,0.01770016],"study_design_scores_gemma":[0.0003918808,0.003014272,0.00955944,0.00001218414,0.0001548073,0.0006358739,0.0000939293,0.002223456,0.9750947,0.0001578597,0.00864344,0.00001822376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862136,0.004707632,0.00369012,0.0002689715,0.0001949794,0.0001162465,0.0004289934,0.000281382,0.004097993],"genre_scores_gemma":[0.9949874,0.001078642,0.001397586,0.00005199038,0.0000216116,0.00006527955,0.0003416935,0.0000106412,0.002045229],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002423846,"threshold_uncertainty_score":0.008108616,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01175150119094972,"score_gpt":0.2647055291050022,"score_spread":0.2529540279140525,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}